| Brown, David Lawrence |
University Of Michigan At Ann Arbor
United States |
Surgical treatment of post-surgical mastectomy pain utilizing the regenerative peripheral nerve interface (RPNI) |
5R21CA234760-02 |
PAR-18-020 (R21 Clinical Trial Optional) |
Diane St Germain, R.N., M.S., C.R.N.P. |
| Bruner, Deborah Watkins |
Nrg Oncology Foundation, Inc.
United States |
NRG Oncology NCORP Research Base |
5UG1CA189867-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Bylund, Carma L. |
University Of Florida
United States |
Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators |
5R01CA253330-02 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Cantuaria, Guilherme |
Northside Hospital Atlanta
United States |
Georgia NCI Community Oncology Research Program (GA NCORP) |
5UG1CA189997-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Carlson, Jay W |
Ozark Health Ventures, Llc
United States |
Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) |
5UG1CA189822-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Cheville, Andrea Lynne |
Mayo Clinic Rochester
United States |
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial |
1R61CA278594-01 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Chung, Ki Young |
Prisma Health-Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
5UG1CA189972-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Cole, Peter D |
Rutgers Biomedical And Health Sciences
United States |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
7R01CA220568-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Conley, Yvette P |
University Of Pittsburgh At Pittsburgh
United States |
Epigenomics of Neurocognitive Function in Breast Cancer |
5R01CA221882-05 |
|
Diane St Germain, R.N., M.S., C.R.N.P. |
| Cope, Timothy C |
Georgia Institute Of Technology
United States |
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
5R01CA221363-05 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |